Garrett C. Moraski

In vitro activity and comparative efficacy of novel nitrofuran-containing ciprofloxacin analogs against bacterial pathogens including ciprofloxacin-resistant Staphylococcus aureus.

The rapid rise of antimicrobial resistance, especially in Staphylococcus aureus, highlights the urgent need for improved antibacterial agents. In 2019 alone, AMR caused an estimated 1.27 million deaths and contributed to nearly 5 million more globally. Here, we present the design, synthesis, and testing of modified cip...